Status:
COMPLETED
Etiology of Lymphopenia in Covid19 Infection
Lead Sponsor:
Dr Medhat Khafagy
Conditions:
Lymphopenia
Eligibility:
All Genders
Brief Summary
Study of the cause of lymphopenia in Covid19 viral infection will be done in 3 cohorts. First cohort will be patients asymptomatic or with mild symptoms. Second cohort will be patients with severe ill...
Detailed Description
Each cohort will include 30 patients. Complete blood count in all patients will be done daily in all patients. Bone marrow aspiration cytology will be done in some selected patients especially those w...
Eligibility Criteria
Inclusion
- Any patient admitted with the diagnosis of Covid19 viral infection
Exclusion
- Any patient who died within one day of admission
Key Trial Info
Start Date :
June 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2021
Estimated Enrollment :
172 Patients enrolled
Trial Details
Trial ID
NCT04404608
Start Date
June 1 2020
End Date
December 1 2021
Last Update
July 20 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Cancer Institute Cairo University
Cairo, Egypt